EXPLORE CONNECTIONS
A low-dose immunotherapy targeting Fc-gamma Receptors and Heparan Sulfate Proteoglycan to impact myeloid cells and control tumor growth in cancers with varying immunosuppressive profiles
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.